Trial
NCT06611436
BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Be Biopharma
Collaborators
—
Condition
Hemophilia B
Intervention
BE-101
Why stopped
The study was terminated due to a strategic business decision and not due to safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-15